NP49425 Generic and Biosimilar Transition Medicines
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- 32 month (est.)
- Value
- £64M
- Sector
- HEALTH
- Published
- 19 Dec 2025
- Delivery
- 01 Feb 2026 to 30 Sep 2028 (est.)
- Deadline
- n/a
Related Terms
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Geochart for 2 buyers and 75 suppliers
2 buyers
- NHS National Services Scotland NSS Edinburgh
34 suppliers
- Mercury Pharmaceuticals London
- Celltrion Healthcare Slough
- Fresenius Kabi Runcorn
- Roche Products Welwyn Garden City
- Janssen Cilag High Wycombe
- Accord Healthcare North Harrow
- Amarox Harrow
- Aop Orphan Birmingham
- Biocon Pharma London
- Celix Pharma London
- Chiesi Manchester
- DR Falk Pharma Bucks
- DR Reddys Laboratories Cambridge
- Ferring Pharmaceuticals West Drayton
- Glenmark Pharmaceuticals Europe Watford
- MSN Labs Letchworth Garden City
- Perennial Pharma Hatfield
- Serb None
- Takeda London
- Teva Castleford
- Stada UK Thornton & Ross Huddersfield
- Viatris UK Healthcare Hatfield
- Wockhardt Wrexham
- Zydus Pharmaceuticals Bristol
- Zentiva Guildford England
- Gedeon Richter London
- Samsung Bioepis Brentford
- Sandoz Surrey
- Vifor Pharma Maidenhead
- Brown & Burk West London
- CST Pharma Walsall
- Pfizer Tadworth
- Amgen Cambridge
- Lupin Healthcare Slough
Description
Supply of generic and biosimilar transition medicines to NHS Scotland.
Lot Division
| 1 | Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) Supply of cytokine modulators (golimumab, tocilizumab, and etanercept) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line. |
| 2 | Cytokine Modulators (Omalizumab) Supply of cytokine modulators (omalizumab) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line. |
| 3 | Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines Supply of gastrointestinal, endocrine, blood, and multiple sclerosis medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line. |
| 4 | Denosumab (Osteoporosis) and Ferric Carboxymaltose Supply of denosumab (osteoporosis) and ferric carboxymaltose to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line. |
| 5 | Apremilast Supply of apremilast to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line. |
| 6 | Cardiovascular and Respiratory Medicines Supply of cardiovascular and respiratory medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line. |
| 7 | Nintedanib Supply of nintedanib to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line. |
| 8 | Cancer Medicines (Group 1) Supply of cancer medicines (group 1) to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line. |
| 9 | Cancer Medicines (Group 2) Supply of cancer medicines (group 2) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line. |
| 10 | Psychiatry and Neurology Medicines Supply of psychiatry and neurology medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line. |
Award Detail
| 1 | Mercury Pharmaceuticals (London)
|
| 2 | Celltrion Healthcare (Slough)
|
| 3 | Fresenius Kabi (Runcorn)
|
| 4 | Roche Products (Welwyn Garden City)
|
| 5 | Janssen Cilag (High Wycombe)
|
| 6 | Mercury Pharmaceuticals (London)
|
| 7 | Celltrion Healthcare (Slough)
|
| 8 | Mercury Pharmaceuticals (London)
|
| 9 | Accord Healthcare (North Harrow)
|
| 10 | Amarox (Harrow)
|
| 11 | Aop Orphan (Birmingham)
|
| 12 | Biocon Pharma (London)
|
| 13 | Celix Pharma (London)
|
| 14 | Chiesi (Manchester)
|
| 15 | DR Falk Pharma (Bucks)
|
| 16 | DR Reddys Laboratories (Cambridge)
|
| 17 | Ferring Pharmaceuticals (West Drayton)
|
| 18 | Glenmark Pharmaceuticals Europe (Watford)
|
| 19 | MSN Labs (Letchworth Garden City)
|
| 20 | Perennial Pharma (Hatfield)
|
| 21 | Serb (None)
|
| 22 | Takeda (London)
|
| 23 | Teva (Castleford)
|
| 24 | Stada UK Thornton & Ross (Huddersfield)
|
| 25 | Viatris UK Healthcare (Hatfield)
|
| 26 | Wockhardt (Wrexham)
|
| 27 | Zydus Pharmaceuticals (Bristol)
|
| 28 | Celltrion Healthcare (Slough)
|
| 29 | Fresenius Kabi (Runcorn)
|
| 30 | Accord Healthcare (North Harrow)
|
| 31 | DR Reddys Laboratories (Cambridge)
|
| 32 | Teva (Castleford)
|
| 33 | Stada UK Thornton & Ross (Huddersfield)
|
| 34 | Zentiva (Guildford England)
|
| 35 | Gedeon Richter (London)
|
| 36 | Samsung Bioepis (Brentford)
|
| 37 | Sandoz (Surrey)
|
| 38 | Vifor Pharma (Maidenhead)
|
| 39 | Accord Healthcare (North Harrow)
|
| 40 | Celix Pharma (London)
|
| 41 | Teva (Castleford)
|
| 42 | Stada UK Thornton & Ross (Huddersfield)
|
| 43 | Brown & Burk (West London)
|
| 44 | Celix Pharma (London)
|
| 45 | Teva (Castleford)
|
| 46 | Stada UK Thornton & Ross (Huddersfield)
|
| 47 | Zentiva (Guildford England)
|
| 48 | Zydus Pharmaceuticals (Bristol)
|
| 49 | CST Pharma (Walsall)
|
| 50 | Celix Pharma (London)
|
| 51 | DR Reddys Laboratories (Cambridge)
|
| 52 | Teva (Castleford)
|
| 53 | Wockhardt (Wrexham)
|
| 54 | Accord Healthcare (North Harrow)
|
| 55 | Mercury Pharmaceuticals (London)
|
| 56 | Accord Healthcare (North Harrow)
|
| 57 | Ferring Pharmaceuticals (West Drayton)
|
| 58 | Glenmark Pharmaceuticals Europe (Watford)
|
| 59 | Teva (Castleford)
|
| 60 | Stada UK Thornton & Ross (Huddersfield)
|
| 61 | Zentiva (Guildford England)
|
| 62 | Pfizer (Tadworth)
|
| 63 | Mercury Pharmaceuticals (London)
|
| 64 | Celltrion Healthcare (Slough)
|
| 65 | Fresenius Kabi (Runcorn)
|
| 66 | Accord Healthcare (North Harrow)
|
| 67 | DR Reddys Laboratories (Cambridge)
|
| 68 | Stada UK Thornton & Ross (Huddersfield)
|
| 69 | Zentiva (Guildford England)
|
| 70 | Gedeon Richter (London)
|
| 71 | Samsung Bioepis (Brentford)
|
| 72 | Sandoz (Surrey)
|
| 73 | Amgen (Cambridge)
|
| 74 | Brown & Burk (West London)
|
| 75 | Lupin Healthcare (Slough)
|
Award Criteria
| Supply Chain | 5.0 |
| PRICE | 95.0 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price.
Other Information
The estimated values referred to in Section II.I.7 and Section V.2.4 (and within all Lots) cover both the initial duration (which is variable, depending on the Lot) and the optional extension period (which is variable, depending on the Lot) -- covering a maximum total duration of forty-eight (48) months. Details of individual product lines awarded within a specific Lot can be requested from the named person at the head of this notice. (SC Ref:819178)
Reference
- FTS 085133-2025